Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients

[1]  A. Israni,et al.  OPTN/SRTR 2020 Annual Data Report: Heart , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  P. Atluri,et al.  HCV Positive Allograft Use in Heart Transplant is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising Outcomes. , 2021, Journal of cardiac failure.

[3]  A. Shah,et al.  Early Outcomes of Multivisceral Transplant using Hepatitis C Positive Donors. , 2020, The Annals of thoracic surgery.

[4]  T. Sundt,et al.  Trends in the use of hepatitis C viremic donor hearts. , 2020, The Journal of thoracic and cardiovascular surgery.

[5]  A. Galloway,et al.  Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation from Hepatitis C Virus Positive Donors. , 2020, Seminars in thoracic and cardiovascular surgery.

[6]  J. Rogers,et al.  Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis. , 2020, JACC. Heart failure.

[7]  J. Hermsen,et al.  Differences in Heart Transplant Volume Growth and Outcomes among Low and High Volume Centers. , 2020, The Journal of Heart and Lung Transplantation.

[8]  H. Karimi-Sari,et al.  Non-atherosclerotic cardiac manifestations of chronic hepatitis C virus infection in the era of direct-acting antiviral agents. , 2020, Atherosclerosis.

[9]  S. Duval,et al.  An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  Chao-Yung Wang,et al.  Risk of cardiac arrhythmias in patients with chronic hepatitis B and C infections - A 13-year nationwide population-based study. , 2019, Journal of cardiology.

[11]  V. Pretorius,et al.  Outcomes of heart transplantation from hepatitis C virus-positive donors. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  B. Greenberg,et al.  The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  P. Camp,et al.  Heart and Lung Transplants from HCV‐Infected Donors to Uninfected Recipients , 2019, The New England journal of medicine.

[14]  J. Lindenfeld,et al.  Trends in Renal Function among Heart-Transplant Recipients of Donor-Derived Hepatitis C Virus , 2019, The Journal of Heart and Lung Transplantation.

[15]  R. Hayes,et al.  Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  L. Kucirka,et al.  The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States , 2018, Annals of Internal Medicine.

[17]  R. Rubin.  Warning for Hepatitis C Treatments Given With Amiodarone , 2015 .

[18]  D. Segev,et al.  Big Data in Organ Transplantation: Registries and Administrative Claims , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  J. McMurray,et al.  How Small Is Too Small? A Systematic Review of Center Volume and Outcome After Cardiac Transplantation , 2012, Circulation. Cardiovascular quality and outcomes.

[20]  J. Shults,et al.  Transplant Center Volume and Outcomes After Liver Retransplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  G. Stukenborg,et al.  Survival After Adult Liver Transplantation Does Not Correlate with Transplant Center Case Volume in the MELD Era , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Merion,et al.  Association of Center Volume with Outcome After Liver and Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  P. Ruiz,et al.  De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. , 1995, Transplantation.